Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Table 5 from Durvalumab plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer
  1. Home
  2. Publications
  3. Table 5 from Durvalumab plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer

Table 5 from Durvalumab plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer

Authors:
  • Peter Schmid
    Peter Schmid
  • Cynthia X. Ma
    Cynthia X. Ma
  • Yeon Hee Park
    Yeon Hee Park
  • SLSimon Lord
    Simon Lord
  • AAAnne Armstrong
    Anne Armstrong
  • SISeock-Ah Im
    Seock-Ah Im
  • SCShin-Cheh Chen
    Shin-Cheh Chen
  • Ricardo Fernandes
    Ricardo Fernandes
  • JJJacek Jassem
    Jacek Jassem
  • PWPiotr J. Wysocki
    Piotr J. Wysocki
  • YLYen-Shen Lu
    Yen-Shen Lu
  • HWHwei-Chung Wang
    Hwei-Chung Wang

Open Access
Publisher website
Google Scholar
  • 14 August 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.33253265
Abstract
Response and survival outcomes by PD-L1 expression.
Keywords
  • LOCALLY ADVANCED
  • BREAST CANCER
  • CANCER RESPONSE
  • METASTATIC TRIPLE-NEGATIVE
  • TRIPLE-NEGATIVE BREAST
  • SURVIVAL OUTCOMES
  • TABLE
  • EXPRESSION
  • PACLITAXEL
  • OLECLUMAB
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.